Nila Infrastructures Ltd
₹6.86
+0.42 (6.52%)
Fri, 06 Nov 2026, 09:26 pm
Nila Infrastructures News
Nila Infra Q2FY27 PAT jumps 62% YoY to ₹10.85 crore
Nila Infrastructures reported a 62% YoY rise in consolidated net profit for Q2FY27, driven by strong revenue growth and reduced losses from joint ventures.
31 Oct 2026
companies
Nila Infra wins Rs 105.02 cr AMC slum rehab order
Nila Infrastructures secured a Rs 105.02 crore order from Ahmedabad Municipal Corporation for slum rehabilitation involving 728 housing units and 25 shops under PMAY.
01 Oct 2026
companies
Nila Infra wins Rs 105.65 Cr AMC project
Nila Infrastructures secured a Rs 105.65 crore slum rehabilitation order from Ahmedabad Municipal Corporation. The deal adds to its order book, which currently covers 1.79 quarters of average revenue.
01 Oct 2026
companies
Nila Infrastructures AGM results declared
Nila Infrastructures Limited shareholders approved FY26 accounts and reappointed directors at its 36th AGM held on July 31, 2026.
31 Jul 2026
companies
Nila Infrastructures Q1FY26 Results
Nila Infrastructures Ltd reported consolidated net profit of ₹8.44 crore in Q1FY26, up 25.7% YoY, driven by a positive swing in joint venture contributions.
25 Jul 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo